EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
Conditions
Glioblastoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Mayo Clinic Hospital, Phoenix, Arizona, United States
University of Southern California, Los Angeles, California, United States
Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
Contact: Study coordinator (Simon Khagi)Stanford Cancer Institute, Palo Alto, California, United States
Contact: Principal Investigator (Lawrence Recht)University of California, San Francisco, California, United States
UF Health Neuromedicine, Gainesville, Florida, United States
Mayo Clinic - Florida, Jacksonville, Florida, United States
Miami Cancer Institute, Miami, Florida, United States
Moffitt Cancer Center, Tampa, Florida, United States
Contact: Principal Investigator (Patrick Grogan)Northwestern Memorial Hospital, Chicago, Illinois, United States
University of Kentucky Medical Center, Lexington, Kentucky, United States
University of Maryland, Baltimore, Maryland, United States
Tufts Medical Center, Boston, Massachusetts, United States
Contact: Principal Investigator (Suriya Jeyapalan)Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Contact: Principal Investigator (Elizabeth Neil)Mayo Clinic - Rochester, Rochester, Minnesota, United States
Washington University, St Louis, Missouri, United States
Renown Regional Medical Center, Reno, Nevada, United States
Contact: Study coordinator (Mauricio Perez-Davila) · mauricio.perezdavila@renown.org · (775) 982-2970John Theurer Cancer Center/ Hackensack Meridian Health, Hackensack, New Jersey, United States
Contact: Principal Investigator (Deric Park)Northwell Health, Lake Success, New York, United States
Contact: Principal Investigator (Samuel Singer)Columbia University Irving Medical Center, New York, New York, United States
Contact: Principal Investigator (Fabio Iwamoto)Montefiore Medical Center- Montefiore Medical Park, The Bronx, New York, United States
Contact: Principal Investigator (Adilia Hormigo)Duke University Medical Center, Durham, North Carolina, United States
Contact: Principal Investigator (Katherine Peters)University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
Contact: Principal Investigator (Herbert Newton)The Cleveland Clinic, Cleveland, Ohio, United States
Contact: Principal Investigator (Mark Malkin)Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Clinical Trials Organization, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Iyad Alnahhas)UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Rhode Island Hospital, Providence, Rhode Island, United States
Contact: Principal Investigator (Eric Wong)The University of Texas, Houston, Texas, United States
University of Texas, MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Chirag Patel)Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States
Contact: Principal Investigator (Howard Colman)Inova Schar Cancer Institute, Fairfax, Virginia, United States
Swedish Medical Center, Seattle, Washington, United States
The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada
CHUM, Montreal, Quebec, Canada
Montreal Neurological Institute-Hospital, Clinical Research Unit, Montreal, Quebec, Canada
Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre hospitalier universitaire de Sherbrooke (CIUSSS de l'Estrie-CHUS), Sherbrooke, Quebec, Canada
Nemocnice Na Homolce, Prague, Czechia
Centre Hospitalier Universitaire de Lyon, Bron, France
Contact: Principal Investigator (Francois Ducray)Hopital de la Timone, Marseille, France
Contact: Principal Investigator (Emeline Tabouret)Hopital Saint-Louis, Paris, France
Contact: Principal Investigator (Stefania Cuzzubbo)Groupe Hospitalier Pitie - Salpetriere, Paris, France
Contact: Principal Investigator (Khe Hoang-Xuan)Institut Claudius Regaud, Toulouse, France
Contact: Study coordinator (Elizabeth Moyal) · Moyal.elizabeth@iuct-oncopole.fr · (+33) 5 31 15 54 45Contact: Principal Investigator (Elizabeth Moyal)Charité Campus Virchow-Klinikum, Berlin, Germany
Universitätsklinikum Essen, Essen, Germany
University Hospital Frankfurt, Frankfurt, Germany
Rambam Medical Center, Haifa, Israel
Rabin Medical Center- Beilinson Hospital, Petah Tikva, Israel
Contact: Principal Investigator (Shlomit Yust-Katz)Chaim Sheba Medical Center, Ramat Gan, Israel
Contact: Principal Investigator (Alisa Talianski)Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel
Contact: Principal Investigator (Deborah Blumenthal)Neuro-Oncologia Clinica Ospedale Molinette - AOU Città della Salute e della Scienza di Torino, Torino, Torino, Italy
Ospedale Bellaria, Bologna, Italy
Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
Ospedale del Mare, Naples, Italy
UOC Oncologia Medica 1 Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy
IRCCS Istituto Clinico Humanitas, Rozzano, Italy
Contact: Study coordinator (Matteo Simonelli) · matteo.simonelli@cancercenter.humanitas.it · +39 02 8224 4559U.O.C. Immunoterapia Oncologica A.O.U. Senese, Policlinico Santa Maria alle Scotte, Siena, Italy
Tokai University Hospital, Isehara, Kanagawa, Japan
Kyushu University Hospital, Fukuoka, Japan
Hokkaido University Hospital, Hokkaido, Japan
Kanazawa University Hospital, Ishikawa, Japan
Kumamoto University Hospital, Kumamoto, Japan
Kyoto University Hospital, Kyoto, Japan
Kyorin University Hospital, Mitaka, Japan
Nagoya University Hospital, Nagoya, Japan
Saitama Medical University International Medical Center, Saitama, Japan
Tohoku University Hospital, Sendai, Japan
National Cancer Center Hospital, Tokyo, Japan
Centrum Onkologii, Bydgoszcz, Poland
Narodowy Instytut Onkologii, Gliwice, Poland
Contact: Study coordinator (Elżbieta Nowicka) · elzbieta.nowicka@gliwice.nio.gov.pl · +48 32 278 86 01Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika-Zakład Teleradioterapii, Lodz, Poland
Hospital Universitario Clínico San Carlos, Madrid, Madrid, Spain
Hospital Universitario Clínico San Carlos, Madrid, Madrid, Spain
Hospital Universitari Vall d'Hebron, Barcelona, Spain
Institut Català d'Oncologia de L'Hospitalet (ICO L'Hospitalet), Barcelona, Spain
Hospital Universitario Reina Sofia, Córdoba, Spain
Hospital Universitario Virgen de las Nieves, Granada, Spain
Hospital Universitario Ramón y Cajal, Madrid, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
Contact: Study coordinator (Juan Manuel Sepulveda Sanchez) · Jmsepulveda76@gmail.com · 0034913908339Hospital Universitario La Paz, Madrid, Spain
Contact: Study coordinator (Virginia Martinez Marín) · virginiamartinezmarin029@gmail.com · 00 34 91 727 75 16Hospital Universitario Virgen del Rocio, Seville, Spain
Hospital Universitari i Politécnic La Fe, Valencia, Spain
University Hospital Basel Medical Oncology, Basel, Switzerland
Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
University Hospital Zurich, Zurich, Switzerland
Queen Elizabeth, Birmingham, United Kingdom
Addenbrooke's Hospital (Cambridge University Hospitals NHS Foundation Trust), Cambridge, United Kingdom
Contact: Principal Investigator (Fiona Harris)Velindre Cancer Centre, Cardiff, United Kingdom
Western General Hospital, Edinburgh, United Kingdom
The Clatterbridge Cancer Centre (Clatterbridge Cancer Centre NHS Foundation Trust), Liverpool, United Kingdom
The Christie Hospital, Manchester, United Kingdom
Weston Park Hospital, Sheffield, United Kingdom
Southampton General Hospital, Southampton, United Kingdom
Royal Marsden, Sutton, United Kingdom
Contact: Principal Investigator (Liam Welsh)